Delivery Order SPE2DR25D9348-SPE2DR26FSQT7
- Not listed
- The Defense Logistics Agency issued a $30,674.50 delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, for Photrexa cross-linking kit 6ml, with an ultimate completion date of February 27, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense...
- The Defense Logistics Agency awarded a $30,674.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, issued January 12, 2026, with an ultimate completion date of February 3, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is...
- The Defense Logistics Agency issued a $15,337.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The delivery order, awarded on January 23, 2026, with an ultimate completion date of February 13, 2026, carries no set-aside designation, indicating the vendor competed in an unrestricted procurement process. This award is issued under DMS...
- The Defense Logistics Agency awarded a $18,404.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit 6ml, with an ultimate completion date of February 11, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge facility, with an ultimate completion date of September 24, 2025. This delivery order was issued without a set-aside designation and represents one of many...
- The Defense Logistics Agency awarded a delivery order valued at $6,134.90 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of February 24, 2026. The award was issued on February 2, 2026, as a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in an unrestricted procurement environment. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler...
- The Defense Logistics Agency awarded a $18,637.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of September 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The company will perform this delivery order at its Park Ridge, IL location, continuing its...
- The Defense Logistics Agency awarded a $9,202.35 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6mL. The contract, issued on January 27, 2026, with a firm fixed-price structure and ultimate completion date of February 18, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance...
- The Defense Logistics Agency awarded a $12,269.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the Photrexa Cross-Linking Kit (6mL), with an ultimate completion date of February 20, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order will be...
- The Defense Logistics Agency awarded a $12,269.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The delivery order, issued on January 20, 2026, with an ultimate completion date of February 10, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued...
- SPE2DR25D9348Indefinite Delivery Contract
- SPE2DR25D9348-SPE2DR26FSQT7Delivery Order
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, for Photrexa Cross-Linking Kit 6ml, with a ceiling value of $3,067.45 and firm fixed-price terms. DMS Pharmaceutical Group is a woman-owned small business. The delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling through December 31, 2036, authorizing DLA to issue firm fixed-price orders for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. Place of performance is Park Ridge, Illinois. Ultimate completion date is March 4, 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 2/9/26 |